COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
HHS Seeks Input on Regulating Deceased-Donor Islet Cell Therapies
September 23, 2026
AABB Calls for Risk-Based Approach to CLIA Modernization
September 23, 2026
FDA Approves Gene Therapy for Pediatric Patients With Sanfilippo Syndrome Type A
September 18, 2026